CD8A and neoplasm: The results found that six tumor-infiltrating immunocytes ( CD8+ T cells, M0 macrophages, M2 macrophages, neutrophils, resting NK cells, and activated dendritic cells) were associated with sorafenib resistance (Figure 1C).